×
The 5 best smartphones of 2025 so far

The 5 best smartphones of 2025 so far

Everyone knows the most exciting smartphones launch in the back half of the calendar. Samsung’s foldables, Google’s latest Pixels, and of course the iPhone 17 are all tipped to come out after June, if rumors are to be believed. Having said that, we can still celebrate the phones that have already come out in 2025. Why not? There are no laws against it.

While it’s true that this list will focus mostly on non-flagship models, that doesn’t mean they aren’t worthy of praise. So far, 2025 has brought us plenty of interesting smartphones at compelling prices, as well as a couple of bona fide flagships that are worth your attention.

So, here are the best smartphones from the first half of 2025. To be clear, this list is not ranked in any particular order. These are just five good phones, folks.

Google Pixel 9a

The Pixel 9a is a great value.
Credit: Joe Maldonado/Mashable

Google’s Pixel A-series of budget phones with flagship-like specs has always provided great value. The 2025 variant is no different.

The Pixel 9a is a lot like previous A-series Pixel phones in that it’s very similar to the base Pixel 9, but with a few little compromises here and there to get the price down to a downright agreeable $499. You get a spiffy 6.3-inch display with a 120Hz refresh rate, a large 5,100mAh battery, and Google’s latest Tensor G4 processor for that price. Sure, you lose a bit of RAM and storage capacity by going with Pixel 9a, but those are small potatoes compared to the ways in which Pixel 9a is similar to Pixel 9, but for less money.

Google also unveiled a new Pixel design with the 9a, which dropped the horizontal camera bar that had adorned Pixel phones for the past several years. Sure, it looks a bit more generic than before, but it also lies flatter on a table than before, too. Between all of that and traditionally solid cameras courtesy of Google, the Pixel 9a might be the best overall value on this list.

Google Pixel 9a

Samsung Galaxy S25 Ultra

Samsung Galaxy S25 Ultra from behind

The S25 Ultra’s rounded corners are very nice.
Credit: Joe Maldonado/Mashable

Full disclosure: I didn’t love the Samsung Galaxy S25 Ultra when I reviewed it earlier this year.

That has less to do with the phone itself and more to do with the increasing creep of AI features into all of our devices, though. The S25 Ultra is not very different from the S24 Ultra in terms of hardware; you get the same display, storage, and RAM specs from the previous model, for the same starting price of $1,299. Some additional AI features were meant to be the main selling point for S25 Ultra, which just isn’t that compelling to me, personally, but YMMV.

Mashable Light Speed

However, the Snapdragon 8 Elite for Galaxy processor inside the S25 Ultra is top-of-the-line stuff, providing the phone with excellent all-around performance. It’s got a big, sturdy battery, a slightly bigger display than the S24 Ultra, and new rounded corners that make it feel much better in the hand. While I wouldn’t recommend upgrading to an S25 Ultra if you already have an S24 Ultra, those with older Samsung handsets who are looking for the best of the best should really look into it. It’s a good phone, if not a mindblowing one.

Samsung - Galaxy S25 Ultra 256GB (Unlocked) - Titanium Blue

Samsung Galaxy S25 Edge

Samsung Galaxy S25 Edge from the side

Tiny.
Credit: Joe Maldonado/Mashable

The other Samsung device on this list also fits under the “good and cool, but not mindblowing” umbrella.

Samsung’s Galaxy S25 Edge has a lot in common with the S25 Ultra. It uses the same processor, its display has the same resolution and refresh rate (although it’s 2/10 of an inch smaller), and even the RAM is the same. You get access to all of the same AI features and even the same 200MP wide lens on the rear for photography.

So, why are these two different phones? Simple: The S25 Edge is way thinner. Coming in at just 5.8mm of thickness, it’s the thinnest phone Samsung sells right now, and is substantially more svelte than the 8.2mm S25 Ultra. Put simply, the S25 Edge looks and feels cool in the hands because of how thin it is. There isn’t a bigger selling point than that, honestly. It feels futuristic in a way nothing else on this list does.

Samsung Galaxy S25 Edge

OnePlus 13

OnePlus 13 display

You may not have heard of it, but it’s good.
Credit: Joe Maldonado/Mashable

The last flagship phone on this list is the OnePlus 13, which comes from a Chinese brand that may not be as well-known in the U.S. as Google, Samsung, and Apple. But that doesn’t mean it should be that way.

OnePlus 13 carries on the tradition of previous OnePlus phones in that it offers flagship specs and features for less than $1,000. At $899, it’s a good deal cheaper than an S25 Ultra, but the two phones are actually pretty comparable. OnePlus’s handset includes a similar Snapdragon 8 Elite processor, 12GB of RAM, and a massive 6,000mAh battery that keeps it alive for longer than 24 hours of normal use. Even our intensive battery testing got a clean 24 hours of screen time out of the OnePlus 13. It has plenty of endurance.

A trio of 50MP cameras on the back and some requisite AI features make the OnePlus 13 a very solid value for those who want flagship performance, but don’t have more than $1,000 to burn on a phone.

OnePlus 13

iPhone 16e

iPhone 16e from behind

The newest iPhone looks simple, but has a lot going for it.
Credit: Stan Schroeder/Mashable

SEE ALSO:

How would the Trump T1 phone compare to the iPhone 16?

Speaking of great battery life, let’s talk about the iPhone 16e.

Nominally Apple’s answer to the Pixel 9a (in that it’s basically an iPhone 16 with some corners cut to bring the price down to $599), the iPhone 16e is an upgrade over Apple’s previous iPhone SE budget line. You get the swanky new A18 Bionic from the iPhone 16, as well as 128GB of starting storage and full support for Apple Intelligence features. The 6.1-inch OLED display is more than good enough for a phone of its price, though it is limited to 60Hz.

Where it really shines, though, is in longevity. Our reviewer was able to get two days of solid use out of a full charge, which is incredible for any phone, much less a budget model. Those looking for a meat-and-potatoes iPhone that will get years of software updates should look no further.

Apple iPhone 16e

Honorable Mention: Motorola Razr Ultra

male model holding motorola razr ultra with wood finish

That wood finish is a beauty.
Credit: Motorola

As one of the only new foldable phones released in 2025, we can’t ignore the Motorola Razr Ultra, especially the version with a slick wood finish. (Well, we could, but we chose not to.) The flagship version of Motorola’s foldable phone series has its fans and critics, and it’s only been out for a couple months. We’re still in the process of testing this phone, and we’re not ready to render a full verdict quite yet. Though, if you want a foldable, we recommend waiting, as Samsung is expected to launch its new Z Fold 7 and Z Flip 7 phones in the coming weeks.

Source link
#smartphones

suggested that GLP-1s can tamp down people’s unhealthy urges for alcohol, cocaine, and even vices like gambling. And earlier this month, researchers in Denmark published data from the first double-blinded, randomized, and placebo-controlled trial of semaglutide for alcohol use disorder in The Lancet. Over a 26-week period, the study found that people on semaglutide consumed less alcohol than those given a placebo and experienced noticeably fewer heavy drinking days when they did drink.

Can Ozempic Treat Alcoholism? Here’s What You Should Know
                Semaglutide (the active ingredient in Ozempic and Wegovy) and other GLP-1 medications have rapidly become some of the most popular drugs in the world. Originally developed for type 2 diabetes, GLP-1s are now better known for treating obesity. In the near future, though, these drugs could have yet another vital use as treatments for alcohol addiction and other substance use disorders. Over the past few years, a growing base of evidence has suggested that GLP-1s can tamp down people’s unhealthy urges for alcohol, cocaine, and even vices like gambling. And earlier this month, researchers in Denmark published data from the first double-blinded, randomized, and placebo-controlled trial of semaglutide for alcohol use disorder in The Lancet. Over a 26-week period, the study found that people on semaglutide consumed less alcohol than those given a placebo and experienced noticeably fewer heavy drinking days when they did drink. © siamionau pavel via Shutterstock There are other similar studies underway, including in the United States. Some are testing semaglutide for other kinds of substance use disorder, like opioids. Others are testing newer drugs like tirzepatide (a dual agonist that pairs GLP-1 with the hunger-related hormone GIP).

 I reached out to an outside expert, Asim Shah, a professor and executive vice chair of psychiatry and behavioral sciences at Baylor College of Medicine, to talk about the emerging science surrounding GLP-1s and addiction treatment. We discussed the leading theory behind why GLP-1s can reduce addiction, his opinion of the recent Lancet trial, and what it will take for these drugs to be widely adopted as treatments for substance use disorders. The following has been lightly edited for clarity and grammar.

 Ed Cara, Gizmodo: Do we have any sort of sense yet as to how or why GLP-1s seem to be working well against substance use disorders? Asim Shah: So the craving, or pleasure, center of the brain is related to dopamine, which is a brain neurotransmitter. Whenever you crave something and you eat it or you take it, that gives you pleasure. That is the dopamine functioning in the brain. And all of this is related to the same thing, whether it’s a craving for food, craving for smoking, craving for alcohol, any drug. That’s the neurobiological mechanism of craving and pleasure, and it’s all the same mechanism.

 © Mohammed_Al_Ali via Shutterstock And incidentally, we found out that the people who were losing weight on these GLP-1s, they often also stopped smoking cigarettes and their addiction got better with alcohol. It was an incidental finding, but it’s something people are now trying to study more closely. Gizmodo: Speaking of studies, what do you make of the newest trial published in The Lancet this month? Shah: So this was a 26 week study, which had about 100 patients, half and half men and women both. In our world, 100 patients is a medium sized study; a larger one might usually have 300, 400, 600 patients. So this is a medium sized study, which is decent. It’s not bad. And in my opinion, it was done pretty well, not a lot of bias in the study that I saw.

 Now, of course, this is not a definitive study. And you need to follow up with these patients after the weeks of study. We call these start-up studies, and they are what we base future, longer and bigger studies on. So it’s a good base, and there are other studies on the way. Gizmodo: Broadly speaking, what are the questions that these longer and larger studies need to try answering? Shah: So there are a couple of things. These are different substances that people are looking at; one is alcohol, one smoking, the other is opiates. So the next studies we should be doing is to see whether GLP-1s like semaglutide can limit more than one of these addictions. Because the mechanism is the same mechanism for all the cravings and the addictions. So can it reduce all of these or just one if somebody is taking it?

 © Sebastien Bozon/AFP via Getty If we do keep seeing an effect here, it’s also important to know how quickly this happens and whether it can be sustained after you stop using a GLP-1. That’s why we have to follow people after these sorts of trials, to see if the effect can last after they stop taking the medication or if it requires people needing to stay on the drug for the effect. Gizmodo: These sort of studies are happening. But what should be the current takeaway for people with these addictions and their doctor? Is this something that could be used in the real world right now? Shah: Because they’re not approved right now, the takeaway should be that if you already have a current indication to take a GLP-1 which is for diabetes or obesity, certainly take it. If you also get an added advantage of stopping your smoking or alcohol use disorder, that is well and good because we don’t have approval for these disorders currently.

 So in other words, if somebody comes to us and says, “Hey, I want to start these medicines for smoking cessation or alcohol use disorder,” we may not be able to prescribe it because there’s no approval. But they can be part of a study which is going on in some centers for those disorders. And if somebody already is using them for diabetes or so, and in addition, they get a benefit for alcoholism, that’s great, too.      #Ozempic #Treat #Alcoholism #Heresaddiction,Alcoholism,GLP-1s,Ozempic,Q&As
© siamionau pavel via Shutterstock

There are other similar studies underway, including in the United States. Some are testing semaglutide for other kinds of substance use disorder, like opioids. Others are testing newer drugs like tirzepatide (a dual agonist that pairs GLP-1 with the hunger-related hormone GIP).

I reached out to an outside expert, Asim Shah, a professor and executive vice chair of psychiatry and behavioral sciences at Baylor College of Medicine, to talk about the emerging science surrounding GLP-1s and addiction treatment. We discussed the leading theory behind why GLP-1s can reduce addiction, his opinion of the recent Lancet trial, and what it will take for these drugs to be widely adopted as treatments for substance use disorders. The following has been lightly edited for clarity and grammar.

Ed Cara, Gizmodo: Do we have any sort of sense yet as to how or why GLP-1s seem to be working well against substance use disorders?

Asim Shah: So the craving, or pleasure, center of the brain is related to dopamine, which is a brain neurotransmitter. Whenever you crave something and you eat it or you take it, that gives you pleasure. That is the dopamine functioning in the brain. And all of this is related to the same thing, whether it’s a craving for food, craving for smoking, craving for alcohol, any drug. That’s the neurobiological mechanism of craving and pleasure, and it’s all the same mechanism.

The obesity medication Saxenda, made with liraglutide
© Mohammed_Al_Ali via Shutterstock

And incidentally, we found out that the people who were losing weight on these GLP-1s, they often also stopped smoking cigarettes and their addiction got better with alcohol. It was an incidental finding, but it’s something people are now trying to study more closely.

Gizmodo: Speaking of studies, what do you make of the newest trial published in The Lancet this month?

Shah: So this was a 26 week study, which had about 100 patients, half and half men and women both. In our world, 100 patients is a medium sized study; a larger one might usually have 300, 400, 600 patients. So this is a medium sized study, which is decent. It’s not bad. And in my opinion, it was done pretty well, not a lot of bias in the study that I saw.

Now, of course, this is not a definitive study. And you need to follow up with these patients after the weeks of study. We call these start-up studies, and they are what we base future, longer and bigger studies on. So it’s a good base, and there are other studies on the way.

Gizmodo: Broadly speaking, what are the questions that these longer and larger studies need to try answering?

Shah: So there are a couple of things.

These are different substances that people are looking at; one is alcohol, one smoking, the other is opiates. So the next studies we should be doing is to see whether GLP-1s like semaglutide can limit more than one of these addictions. Because the mechanism is the same mechanism for all the cravings and the addictions. So can it reduce all of these or just one if somebody is taking it?

Boxes of the GLP-1 medication Ozempic
© Sebastien Bozon/AFP via Getty

If we do keep seeing an effect here, it’s also important to know how quickly this happens and whether it can be sustained after you stop using a GLP-1. That’s why we have to follow people after these sorts of trials, to see if the effect can last after they stop taking the medication or if it requires people needing to stay on the drug for the effect.

Gizmodo: These sort of studies are happening. But what should be the current takeaway for people with these addictions and their doctor? Is this something that could be used in the real world right now?

Shah: Because they’re not approved right now, the takeaway should be that if you already have a current indication to take a GLP-1 which is for diabetes or obesity, certainly take it. If you also get an added advantage of stopping your smoking or alcohol use disorder, that is well and good because we don’t have approval for these disorders currently.

So in other words, if somebody comes to us and says, “Hey, I want to start these medicines for smoking cessation or alcohol use disorder,” we may not be able to prescribe it because there’s no approval. But they can be part of a study which is going on in some centers for those disorders. And if somebody already is using them for diabetes or so, and in addition, they get a benefit for alcoholism, that’s great, too.

#Ozempic #Treat #Alcoholism #Heresaddiction,Alcoholism,GLP-1s,Ozempic,Q&As">Can Ozempic Treat Alcoholism? Here’s What You Should Know
                Semaglutide (the active ingredient in Ozempic and Wegovy) and other GLP-1 medications have rapidly become some of the most popular drugs in the world. Originally developed for type 2 diabetes, GLP-1s are now better known for treating obesity. In the near future, though, these drugs could have yet another vital use as treatments for alcohol addiction and other substance use disorders. Over the past few years, a growing base of evidence has suggested that GLP-1s can tamp down people’s unhealthy urges for alcohol, cocaine, and even vices like gambling. And earlier this month, researchers in Denmark published data from the first double-blinded, randomized, and placebo-controlled trial of semaglutide for alcohol use disorder in The Lancet. Over a 26-week period, the study found that people on semaglutide consumed less alcohol than those given a placebo and experienced noticeably fewer heavy drinking days when they did drink. © siamionau pavel via Shutterstock There are other similar studies underway, including in the United States. Some are testing semaglutide for other kinds of substance use disorder, like opioids. Others are testing newer drugs like tirzepatide (a dual agonist that pairs GLP-1 with the hunger-related hormone GIP).

 I reached out to an outside expert, Asim Shah, a professor and executive vice chair of psychiatry and behavioral sciences at Baylor College of Medicine, to talk about the emerging science surrounding GLP-1s and addiction treatment. We discussed the leading theory behind why GLP-1s can reduce addiction, his opinion of the recent Lancet trial, and what it will take for these drugs to be widely adopted as treatments for substance use disorders. The following has been lightly edited for clarity and grammar.

 Ed Cara, Gizmodo: Do we have any sort of sense yet as to how or why GLP-1s seem to be working well against substance use disorders? Asim Shah: So the craving, or pleasure, center of the brain is related to dopamine, which is a brain neurotransmitter. Whenever you crave something and you eat it or you take it, that gives you pleasure. That is the dopamine functioning in the brain. And all of this is related to the same thing, whether it’s a craving for food, craving for smoking, craving for alcohol, any drug. That’s the neurobiological mechanism of craving and pleasure, and it’s all the same mechanism.

 © Mohammed_Al_Ali via Shutterstock And incidentally, we found out that the people who were losing weight on these GLP-1s, they often also stopped smoking cigarettes and their addiction got better with alcohol. It was an incidental finding, but it’s something people are now trying to study more closely. Gizmodo: Speaking of studies, what do you make of the newest trial published in The Lancet this month? Shah: So this was a 26 week study, which had about 100 patients, half and half men and women both. In our world, 100 patients is a medium sized study; a larger one might usually have 300, 400, 600 patients. So this is a medium sized study, which is decent. It’s not bad. And in my opinion, it was done pretty well, not a lot of bias in the study that I saw.

 Now, of course, this is not a definitive study. And you need to follow up with these patients after the weeks of study. We call these start-up studies, and they are what we base future, longer and bigger studies on. So it’s a good base, and there are other studies on the way. Gizmodo: Broadly speaking, what are the questions that these longer and larger studies need to try answering? Shah: So there are a couple of things. These are different substances that people are looking at; one is alcohol, one smoking, the other is opiates. So the next studies we should be doing is to see whether GLP-1s like semaglutide can limit more than one of these addictions. Because the mechanism is the same mechanism for all the cravings and the addictions. So can it reduce all of these or just one if somebody is taking it?

 © Sebastien Bozon/AFP via Getty If we do keep seeing an effect here, it’s also important to know how quickly this happens and whether it can be sustained after you stop using a GLP-1. That’s why we have to follow people after these sorts of trials, to see if the effect can last after they stop taking the medication or if it requires people needing to stay on the drug for the effect. Gizmodo: These sort of studies are happening. But what should be the current takeaway for people with these addictions and their doctor? Is this something that could be used in the real world right now? Shah: Because they’re not approved right now, the takeaway should be that if you already have a current indication to take a GLP-1 which is for diabetes or obesity, certainly take it. If you also get an added advantage of stopping your smoking or alcohol use disorder, that is well and good because we don’t have approval for these disorders currently.

 So in other words, if somebody comes to us and says, “Hey, I want to start these medicines for smoking cessation or alcohol use disorder,” we may not be able to prescribe it because there’s no approval. But they can be part of a study which is going on in some centers for those disorders. And if somebody already is using them for diabetes or so, and in addition, they get a benefit for alcoholism, that’s great, too.      #Ozempic #Treat #Alcoholism #Heresaddiction,Alcoholism,GLP-1s,Ozempic,Q&As

that GLP-1s can tamp down people’s unhealthy urges for alcohol, cocaine, and even vices like gambling. And earlier this month, researchers in Denmark published data from the first double-blinded, randomized, and placebo-controlled trial of semaglutide for alcohol use disorder in The Lancet. Over a 26-week period, the study found that people on semaglutide consumed less alcohol than those given a placebo and experienced noticeably fewer heavy drinking days when they did drink.

Can Ozempic Treat Alcoholism? Here’s What You Should Know
                Semaglutide (the active ingredient in Ozempic and Wegovy) and other GLP-1 medications have rapidly become some of the most popular drugs in the world. Originally developed for type 2 diabetes, GLP-1s are now better known for treating obesity. In the near future, though, these drugs could have yet another vital use as treatments for alcohol addiction and other substance use disorders. Over the past few years, a growing base of evidence has suggested that GLP-1s can tamp down people’s unhealthy urges for alcohol, cocaine, and even vices like gambling. And earlier this month, researchers in Denmark published data from the first double-blinded, randomized, and placebo-controlled trial of semaglutide for alcohol use disorder in The Lancet. Over a 26-week period, the study found that people on semaglutide consumed less alcohol than those given a placebo and experienced noticeably fewer heavy drinking days when they did drink. © siamionau pavel via Shutterstock There are other similar studies underway, including in the United States. Some are testing semaglutide for other kinds of substance use disorder, like opioids. Others are testing newer drugs like tirzepatide (a dual agonist that pairs GLP-1 with the hunger-related hormone GIP).

 I reached out to an outside expert, Asim Shah, a professor and executive vice chair of psychiatry and behavioral sciences at Baylor College of Medicine, to talk about the emerging science surrounding GLP-1s and addiction treatment. We discussed the leading theory behind why GLP-1s can reduce addiction, his opinion of the recent Lancet trial, and what it will take for these drugs to be widely adopted as treatments for substance use disorders. The following has been lightly edited for clarity and grammar.

 Ed Cara, Gizmodo: Do we have any sort of sense yet as to how or why GLP-1s seem to be working well against substance use disorders? Asim Shah: So the craving, or pleasure, center of the brain is related to dopamine, which is a brain neurotransmitter. Whenever you crave something and you eat it or you take it, that gives you pleasure. That is the dopamine functioning in the brain. And all of this is related to the same thing, whether it’s a craving for food, craving for smoking, craving for alcohol, any drug. That’s the neurobiological mechanism of craving and pleasure, and it’s all the same mechanism.

 © Mohammed_Al_Ali via Shutterstock And incidentally, we found out that the people who were losing weight on these GLP-1s, they often also stopped smoking cigarettes and their addiction got better with alcohol. It was an incidental finding, but it’s something people are now trying to study more closely. Gizmodo: Speaking of studies, what do you make of the newest trial published in The Lancet this month? Shah: So this was a 26 week study, which had about 100 patients, half and half men and women both. In our world, 100 patients is a medium sized study; a larger one might usually have 300, 400, 600 patients. So this is a medium sized study, which is decent. It’s not bad. And in my opinion, it was done pretty well, not a lot of bias in the study that I saw.

 Now, of course, this is not a definitive study. And you need to follow up with these patients after the weeks of study. We call these start-up studies, and they are what we base future, longer and bigger studies on. So it’s a good base, and there are other studies on the way. Gizmodo: Broadly speaking, what are the questions that these longer and larger studies need to try answering? Shah: So there are a couple of things. These are different substances that people are looking at; one is alcohol, one smoking, the other is opiates. So the next studies we should be doing is to see whether GLP-1s like semaglutide can limit more than one of these addictions. Because the mechanism is the same mechanism for all the cravings and the addictions. So can it reduce all of these or just one if somebody is taking it?

 © Sebastien Bozon/AFP via Getty If we do keep seeing an effect here, it’s also important to know how quickly this happens and whether it can be sustained after you stop using a GLP-1. That’s why we have to follow people after these sorts of trials, to see if the effect can last after they stop taking the medication or if it requires people needing to stay on the drug for the effect. Gizmodo: These sort of studies are happening. But what should be the current takeaway for people with these addictions and their doctor? Is this something that could be used in the real world right now? Shah: Because they’re not approved right now, the takeaway should be that if you already have a current indication to take a GLP-1 which is for diabetes or obesity, certainly take it. If you also get an added advantage of stopping your smoking or alcohol use disorder, that is well and good because we don’t have approval for these disorders currently.

 So in other words, if somebody comes to us and says, “Hey, I want to start these medicines for smoking cessation or alcohol use disorder,” we may not be able to prescribe it because there’s no approval. But they can be part of a study which is going on in some centers for those disorders. And if somebody already is using them for diabetes or so, and in addition, they get a benefit for alcoholism, that’s great, too.      #Ozempic #Treat #Alcoholism #Heresaddiction,Alcoholism,GLP-1s,Ozempic,Q&As
© siamionau pavel via Shutterstock

There are other similar studies underway, including in the United States. Some are testing semaglutide for other kinds of substance use disorder, like opioids. Others are testing newer drugs like tirzepatide (a dual agonist that pairs GLP-1 with the hunger-related hormone GIP).

I reached out to an outside expert, Asim Shah, a professor and executive vice chair of psychiatry and behavioral sciences at Baylor College of Medicine, to talk about the emerging science surrounding GLP-1s and addiction treatment. We discussed the leading theory behind why GLP-1s can reduce addiction, his opinion of the recent Lancet trial, and what it will take for these drugs to be widely adopted as treatments for substance use disorders. The following has been lightly edited for clarity and grammar.

Ed Cara, Gizmodo: Do we have any sort of sense yet as to how or why GLP-1s seem to be working well against substance use disorders?

Asim Shah: So the craving, or pleasure, center of the brain is related to dopamine, which is a brain neurotransmitter. Whenever you crave something and you eat it or you take it, that gives you pleasure. That is the dopamine functioning in the brain. And all of this is related to the same thing, whether it’s a craving for food, craving for smoking, craving for alcohol, any drug. That’s the neurobiological mechanism of craving and pleasure, and it’s all the same mechanism.

The obesity medication Saxenda, made with liraglutide
© Mohammed_Al_Ali via Shutterstock

And incidentally, we found out that the people who were losing weight on these GLP-1s, they often also stopped smoking cigarettes and their addiction got better with alcohol. It was an incidental finding, but it’s something people are now trying to study more closely.

Gizmodo: Speaking of studies, what do you make of the newest trial published in The Lancet this month?

Shah: So this was a 26 week study, which had about 100 patients, half and half men and women both. In our world, 100 patients is a medium sized study; a larger one might usually have 300, 400, 600 patients. So this is a medium sized study, which is decent. It’s not bad. And in my opinion, it was done pretty well, not a lot of bias in the study that I saw.

Now, of course, this is not a definitive study. And you need to follow up with these patients after the weeks of study. We call these start-up studies, and they are what we base future, longer and bigger studies on. So it’s a good base, and there are other studies on the way.

Gizmodo: Broadly speaking, what are the questions that these longer and larger studies need to try answering?

Shah: So there are a couple of things.

These are different substances that people are looking at; one is alcohol, one smoking, the other is opiates. So the next studies we should be doing is to see whether GLP-1s like semaglutide can limit more than one of these addictions. Because the mechanism is the same mechanism for all the cravings and the addictions. So can it reduce all of these or just one if somebody is taking it?

Boxes of the GLP-1 medication Ozempic
© Sebastien Bozon/AFP via Getty

If we do keep seeing an effect here, it’s also important to know how quickly this happens and whether it can be sustained after you stop using a GLP-1. That’s why we have to follow people after these sorts of trials, to see if the effect can last after they stop taking the medication or if it requires people needing to stay on the drug for the effect.

Gizmodo: These sort of studies are happening. But what should be the current takeaway for people with these addictions and their doctor? Is this something that could be used in the real world right now?

Shah: Because they’re not approved right now, the takeaway should be that if you already have a current indication to take a GLP-1 which is for diabetes or obesity, certainly take it. If you also get an added advantage of stopping your smoking or alcohol use disorder, that is well and good because we don’t have approval for these disorders currently.

So in other words, if somebody comes to us and says, “Hey, I want to start these medicines for smoking cessation or alcohol use disorder,” we may not be able to prescribe it because there’s no approval. But they can be part of a study which is going on in some centers for those disorders. And if somebody already is using them for diabetes or so, and in addition, they get a benefit for alcoholism, that’s great, too.

#Ozempic #Treat #Alcoholism #Heresaddiction,Alcoholism,GLP-1s,Ozempic,Q&As">Can Ozempic Treat Alcoholism? Here’s What You Should Know

Semaglutide (the active ingredient in Ozempic and Wegovy) and other GLP-1 medications have rapidly become some of the most popular drugs in the world. Originally developed for type 2 diabetes, GLP-1s are now better known for treating obesity. In the near future, though, these drugs could have yet another vital use as treatments for alcohol addiction and other substance use disorders.

Over the past few years, a growing base of evidence has suggested that GLP-1s can tamp down people’s unhealthy urges for alcohol, cocaine, and even vices like gambling. And earlier this month, researchers in Denmark published data from the first double-blinded, randomized, and placebo-controlled trial of semaglutide for alcohol use disorder in The Lancet. Over a 26-week period, the study found that people on semaglutide consumed less alcohol than those given a placebo and experienced noticeably fewer heavy drinking days when they did drink.

Can Ozempic Treat Alcoholism? Here’s What You Should Know
                Semaglutide (the active ingredient in Ozempic and Wegovy) and other GLP-1 medications have rapidly become some of the most popular drugs in the world. Originally developed for type 2 diabetes, GLP-1s are now better known for treating obesity. In the near future, though, these drugs could have yet another vital use as treatments for alcohol addiction and other substance use disorders. Over the past few years, a growing base of evidence has suggested that GLP-1s can tamp down people’s unhealthy urges for alcohol, cocaine, and even vices like gambling. And earlier this month, researchers in Denmark published data from the first double-blinded, randomized, and placebo-controlled trial of semaglutide for alcohol use disorder in The Lancet. Over a 26-week period, the study found that people on semaglutide consumed less alcohol than those given a placebo and experienced noticeably fewer heavy drinking days when they did drink. © siamionau pavel via Shutterstock There are other similar studies underway, including in the United States. Some are testing semaglutide for other kinds of substance use disorder, like opioids. Others are testing newer drugs like tirzepatide (a dual agonist that pairs GLP-1 with the hunger-related hormone GIP).

 I reached out to an outside expert, Asim Shah, a professor and executive vice chair of psychiatry and behavioral sciences at Baylor College of Medicine, to talk about the emerging science surrounding GLP-1s and addiction treatment. We discussed the leading theory behind why GLP-1s can reduce addiction, his opinion of the recent Lancet trial, and what it will take for these drugs to be widely adopted as treatments for substance use disorders. The following has been lightly edited for clarity and grammar.

 Ed Cara, Gizmodo: Do we have any sort of sense yet as to how or why GLP-1s seem to be working well against substance use disorders? Asim Shah: So the craving, or pleasure, center of the brain is related to dopamine, which is a brain neurotransmitter. Whenever you crave something and you eat it or you take it, that gives you pleasure. That is the dopamine functioning in the brain. And all of this is related to the same thing, whether it’s a craving for food, craving for smoking, craving for alcohol, any drug. That’s the neurobiological mechanism of craving and pleasure, and it’s all the same mechanism.

 © Mohammed_Al_Ali via Shutterstock And incidentally, we found out that the people who were losing weight on these GLP-1s, they often also stopped smoking cigarettes and their addiction got better with alcohol. It was an incidental finding, but it’s something people are now trying to study more closely. Gizmodo: Speaking of studies, what do you make of the newest trial published in The Lancet this month? Shah: So this was a 26 week study, which had about 100 patients, half and half men and women both. In our world, 100 patients is a medium sized study; a larger one might usually have 300, 400, 600 patients. So this is a medium sized study, which is decent. It’s not bad. And in my opinion, it was done pretty well, not a lot of bias in the study that I saw.

 Now, of course, this is not a definitive study. And you need to follow up with these patients after the weeks of study. We call these start-up studies, and they are what we base future, longer and bigger studies on. So it’s a good base, and there are other studies on the way. Gizmodo: Broadly speaking, what are the questions that these longer and larger studies need to try answering? Shah: So there are a couple of things. These are different substances that people are looking at; one is alcohol, one smoking, the other is opiates. So the next studies we should be doing is to see whether GLP-1s like semaglutide can limit more than one of these addictions. Because the mechanism is the same mechanism for all the cravings and the addictions. So can it reduce all of these or just one if somebody is taking it?

 © Sebastien Bozon/AFP via Getty If we do keep seeing an effect here, it’s also important to know how quickly this happens and whether it can be sustained after you stop using a GLP-1. That’s why we have to follow people after these sorts of trials, to see if the effect can last after they stop taking the medication or if it requires people needing to stay on the drug for the effect. Gizmodo: These sort of studies are happening. But what should be the current takeaway for people with these addictions and their doctor? Is this something that could be used in the real world right now? Shah: Because they’re not approved right now, the takeaway should be that if you already have a current indication to take a GLP-1 which is for diabetes or obesity, certainly take it. If you also get an added advantage of stopping your smoking or alcohol use disorder, that is well and good because we don’t have approval for these disorders currently.

 So in other words, if somebody comes to us and says, “Hey, I want to start these medicines for smoking cessation or alcohol use disorder,” we may not be able to prescribe it because there’s no approval. But they can be part of a study which is going on in some centers for those disorders. And if somebody already is using them for diabetes or so, and in addition, they get a benefit for alcoholism, that’s great, too.      #Ozempic #Treat #Alcoholism #Heresaddiction,Alcoholism,GLP-1s,Ozempic,Q&As
© siamionau pavel via Shutterstock

There are other similar studies underway, including in the United States. Some are testing semaglutide for other kinds of substance use disorder, like opioids. Others are testing newer drugs like tirzepatide (a dual agonist that pairs GLP-1 with the hunger-related hormone GIP).

I reached out to an outside expert, Asim Shah, a professor and executive vice chair of psychiatry and behavioral sciences at Baylor College of Medicine, to talk about the emerging science surrounding GLP-1s and addiction treatment. We discussed the leading theory behind why GLP-1s can reduce addiction, his opinion of the recent Lancet trial, and what it will take for these drugs to be widely adopted as treatments for substance use disorders. The following has been lightly edited for clarity and grammar.

Ed Cara, Gizmodo: Do we have any sort of sense yet as to how or why GLP-1s seem to be working well against substance use disorders?

Asim Shah: So the craving, or pleasure, center of the brain is related to dopamine, which is a brain neurotransmitter. Whenever you crave something and you eat it or you take it, that gives you pleasure. That is the dopamine functioning in the brain. And all of this is related to the same thing, whether it’s a craving for food, craving for smoking, craving for alcohol, any drug. That’s the neurobiological mechanism of craving and pleasure, and it’s all the same mechanism.

The obesity medication Saxenda, made with liraglutide
© Mohammed_Al_Ali via Shutterstock

And incidentally, we found out that the people who were losing weight on these GLP-1s, they often also stopped smoking cigarettes and their addiction got better with alcohol. It was an incidental finding, but it’s something people are now trying to study more closely.

Gizmodo: Speaking of studies, what do you make of the newest trial published in The Lancet this month?

Shah: So this was a 26 week study, which had about 100 patients, half and half men and women both. In our world, 100 patients is a medium sized study; a larger one might usually have 300, 400, 600 patients. So this is a medium sized study, which is decent. It’s not bad. And in my opinion, it was done pretty well, not a lot of bias in the study that I saw.

Now, of course, this is not a definitive study. And you need to follow up with these patients after the weeks of study. We call these start-up studies, and they are what we base future, longer and bigger studies on. So it’s a good base, and there are other studies on the way.

Gizmodo: Broadly speaking, what are the questions that these longer and larger studies need to try answering?

Shah: So there are a couple of things.

These are different substances that people are looking at; one is alcohol, one smoking, the other is opiates. So the next studies we should be doing is to see whether GLP-1s like semaglutide can limit more than one of these addictions. Because the mechanism is the same mechanism for all the cravings and the addictions. So can it reduce all of these or just one if somebody is taking it?

Boxes of the GLP-1 medication Ozempic
© Sebastien Bozon/AFP via Getty

If we do keep seeing an effect here, it’s also important to know how quickly this happens and whether it can be sustained after you stop using a GLP-1. That’s why we have to follow people after these sorts of trials, to see if the effect can last after they stop taking the medication or if it requires people needing to stay on the drug for the effect.

Gizmodo: These sort of studies are happening. But what should be the current takeaway for people with these addictions and their doctor? Is this something that could be used in the real world right now?

Shah: Because they’re not approved right now, the takeaway should be that if you already have a current indication to take a GLP-1 which is for diabetes or obesity, certainly take it. If you also get an added advantage of stopping your smoking or alcohol use disorder, that is well and good because we don’t have approval for these disorders currently.

So in other words, if somebody comes to us and says, “Hey, I want to start these medicines for smoking cessation or alcohol use disorder,” we may not be able to prescribe it because there’s no approval. But they can be part of a study which is going on in some centers for those disorders. And if somebody already is using them for diabetes or so, and in addition, they get a benefit for alcoholism, that’s great, too.

#Ozempic #Treat #Alcoholism #Heresaddiction,Alcoholism,GLP-1s,Ozempic,Q&As
Bartesian is the Keurig of cocktails. After trying several automatic cocktail makers on the market, it was the only cocktail maker I could see fitting into my normal routine. It works like any capsule-style device, but with booze. You fill the Bartesian’s glass bottles with your liquor of choice, make sure there’s water in the reservoir, plop in a cocktail capsule (these typically cost $2-3), choose your drink strength, press “mix,” and then a drink comes out. (If you’ve got kids, the Bartesian Professional version comes with a lock that will stymie curious fingers.)

Do you need a Bartesian to make cocktails? Of course you don’t. You can dump tequila into sour mix anytime and call it a margarita. But perhaps you’d like to make an espresso martini, a blackberry margarita, and also a Long Island Iced Tea? The Bartesian is a sort of shortcut to a home bar, without having to store all the mixers—and a bit of a novelty. It will be fun, and silly, and the drinks are kind of fine in a Spring Break way: strong and sweet and with sometimes fun flavors. Don’t expect sophistication. Expect a bit of a party trick, the sort of thing that makes a summer a little more fun.

You’ll, of course, want a Bartesian coupon to make that fun more accessible. Luckily, the current Bartesian discount codes are good for up to 35% off.

Save up to 35% With a Bartesian Cocktail Subscription

Standard pods on the Bartesian come in packs of 8, for $20 to $25. But if you know you plan to use the cocktail machine often—garden parties, art gallery openings, a really cool barber shop, an interesting home life, Friday afternoon margaritaville—the easiest way to save on the Bartesian pods is to sign up for a cocktail subscription. No Bartesian subscription discount codes are required. Subscription boxes always cost $20, so get the ones that’d be otherwise expensive for a 20% discount—then get additional tiered discounts of Bartesian depending on volume and frequency. If you order often or in large quatnities, this can add up to 35% off the regular price.

Save 15% (Or More) When You Purchase a Cocktail Bundle

I can’t tell you what to do. But at current discounts on Bartesian cocktail bundles and add-ons, only a sucker buys a Bartesian as a standalone item. If you flip to the Bartesian bundles page, you can find multiple bundles that offer glassware and cocktail variety packs for about the same price as the machine by itself. The Mom Bundle in particular costs less than the Bartesian Pro machine by itself, but includes 8 margarita capsules and two glasses. As of April 2026, Bartesian is also offering a Mother’s Day deal, offering $100 off the Bartesian Pro or the Bartesian Duet as long as you add a cocktail capsule pack to your order. Presumably, if you are buying the machine, you’ll want the cocktail capsules anyway.

Bartesian Rewards Club: Get More for Your Buck

Bartesian also has a loyalty program that they’re calling, alternately, the Bartesian Club, the Bartesian Rewards Club, or Bartesian Mixologist Rewards. One way or the other, it doesn’t cost anything to sign up, and you get discounts. Basically, you earn 4 to 6 points per dollar you spend, plus get additional points for referring other customers, following Bartesian on Instagram, or just having a birthday. If you get a thousand points, you can redeem them for a $10 discount. There are also exclusive members-only tiers. Rewards are bigger if you’re a big spender. Here are the three membership tiers.

Earn 2,500 Points and Give $25 When You Refer a Friend

The biggest rewards bonus comes when you refer a friend who then buys a Bartesian or otherwise spends at least $150 on the site. Use the friend referral page here, and your friend will get a $25 discount using a Bertesian referral coupon code if they buy a Bartesian after using your link. You’ll also get 2,500 points on the Bartesian Rewards Club. Which is to say, you also get $25.

#Top #Bartesian #Discount #Codescoupons,shopping">Top Bartesian Discount Codes: 35% OffBartesian is the Keurig of cocktails. After trying several automatic cocktail makers on the market, it was the only cocktail maker I could see fitting into my normal routine. It works like any capsule-style device, but with booze. You fill the Bartesian’s glass bottles with your liquor of choice, make sure there’s water in the reservoir, plop in a cocktail capsule (these typically cost -3), choose your drink strength, press “mix,” and then a drink comes out. (If you’ve got kids, the Bartesian Professional version comes with a lock that will stymie curious fingers.)Do you need a Bartesian to make cocktails? Of course you don’t. You can dump tequila into sour mix anytime and call it a margarita. But perhaps you’d like to make an espresso martini, a blackberry margarita, and also a Long Island Iced Tea? The Bartesian is a sort of shortcut to a home bar, without having to store all the mixers—and a bit of a novelty. It will be fun, and silly, and the drinks are kind of fine in a Spring Break way: strong and sweet and with sometimes fun flavors. Don’t expect sophistication. Expect a bit of a party trick, the sort of thing that makes a summer a little more fun.You’ll, of course, want a Bartesian coupon to make that fun more accessible. Luckily, the current Bartesian discount codes are good for up to 35% off.Save up to 35% With a Bartesian Cocktail SubscriptionStandard pods on the Bartesian come in packs of 8, for  to . But if you know you plan to use the cocktail machine often—garden parties, art gallery openings, a really cool barber shop, an interesting home life, Friday afternoon margaritaville—the easiest way to save on the Bartesian pods is to sign up for a cocktail subscription. No Bartesian subscription discount codes are required. Subscription boxes always cost , so get the ones that’d be otherwise expensive for a 20% discount—then get additional tiered discounts of Bartesian depending on volume and frequency. If you order often or in large quatnities, this can add up to 35% off the regular price.Save 15% (Or More) When You Purchase a Cocktail BundleI can’t tell you what to do. But at current discounts on Bartesian cocktail bundles and add-ons, only a sucker buys a Bartesian as a standalone item. If you flip to the Bartesian bundles page, you can find multiple bundles that offer glassware and cocktail variety packs for about the same price as the machine by itself. The Mom Bundle in particular costs less than the Bartesian Pro machine by itself, but includes 8 margarita capsules and two glasses. As of April 2026, Bartesian is also offering a Mother’s Day deal, offering 0 off the Bartesian Pro or the Bartesian Duet as long as you add a cocktail capsule pack to your order. Presumably, if you are buying the machine, you’ll want the cocktail capsules anyway.Bartesian Rewards Club: Get More for Your BuckBartesian also has a loyalty program that they’re calling, alternately, the Bartesian Club, the Bartesian Rewards Club, or Bartesian Mixologist Rewards. One way or the other, it doesn’t cost anything to sign up, and you get discounts. Basically, you earn 4 to 6 points per dollar you spend, plus get additional points for referring other customers, following Bartesian on Instagram, or just having a birthday. If you get a thousand points, you can redeem them for a  discount. There are also exclusive members-only tiers. Rewards are bigger if you’re a big spender. Here are the three membership tiers.Earn 2,500 Points and Give  When You Refer a FriendThe biggest rewards bonus comes when you refer a friend who then buys a Bartesian or otherwise spends at least 0 on the site. Use the friend referral page here, and your friend will get a  discount using a Bertesian referral coupon code if they buy a Bartesian after using your link. You’ll also get 2,500 points on the Bartesian Rewards Club. Which is to say, you also get .#Top #Bartesian #Discount #Codescoupons,shopping

trying several automatic cocktail makers on the market, it was the only cocktail maker I could see fitting into my normal routine. It works like any capsule-style device, but with booze. You fill the Bartesian’s glass bottles with your liquor of choice, make sure there’s water in the reservoir, plop in a cocktail capsule (these typically cost $2-3), choose your drink strength, press “mix,” and then a drink comes out. (If you’ve got kids, the Bartesian Professional version comes with a lock that will stymie curious fingers.)

Do you need a Bartesian to make cocktails? Of course you don’t. You can dump tequila into sour mix anytime and call it a margarita. But perhaps you’d like to make an espresso martini, a blackberry margarita, and also a Long Island Iced Tea? The Bartesian is a sort of shortcut to a home bar, without having to store all the mixers—and a bit of a novelty. It will be fun, and silly, and the drinks are kind of fine in a Spring Break way: strong and sweet and with sometimes fun flavors. Don’t expect sophistication. Expect a bit of a party trick, the sort of thing that makes a summer a little more fun.

You’ll, of course, want a Bartesian coupon to make that fun more accessible. Luckily, the current Bartesian discount codes are good for up to 35% off.

Save up to 35% With a Bartesian Cocktail Subscription

Standard pods on the Bartesian come in packs of 8, for $20 to $25. But if you know you plan to use the cocktail machine often—garden parties, art gallery openings, a really cool barber shop, an interesting home life, Friday afternoon margaritaville—the easiest way to save on the Bartesian pods is to sign up for a cocktail subscription. No Bartesian subscription discount codes are required. Subscription boxes always cost $20, so get the ones that’d be otherwise expensive for a 20% discount—then get additional tiered discounts of Bartesian depending on volume and frequency. If you order often or in large quatnities, this can add up to 35% off the regular price.

Save 15% (Or More) When You Purchase a Cocktail Bundle

I can’t tell you what to do. But at current discounts on Bartesian cocktail bundles and add-ons, only a sucker buys a Bartesian as a standalone item. If you flip to the Bartesian bundles page, you can find multiple bundles that offer glassware and cocktail variety packs for about the same price as the machine by itself. The Mom Bundle in particular costs less than the Bartesian Pro machine by itself, but includes 8 margarita capsules and two glasses. As of April 2026, Bartesian is also offering a Mother’s Day deal, offering $100 off the Bartesian Pro or the Bartesian Duet as long as you add a cocktail capsule pack to your order. Presumably, if you are buying the machine, you’ll want the cocktail capsules anyway.

Bartesian Rewards Club: Get More for Your Buck

Bartesian also has a loyalty program that they’re calling, alternately, the Bartesian Club, the Bartesian Rewards Club, or Bartesian Mixologist Rewards. One way or the other, it doesn’t cost anything to sign up, and you get discounts. Basically, you earn 4 to 6 points per dollar you spend, plus get additional points for referring other customers, following Bartesian on Instagram, or just having a birthday. If you get a thousand points, you can redeem them for a $10 discount. There are also exclusive members-only tiers. Rewards are bigger if you’re a big spender. Here are the three membership tiers.

Earn 2,500 Points and Give $25 When You Refer a Friend

The biggest rewards bonus comes when you refer a friend who then buys a Bartesian or otherwise spends at least $150 on the site. Use the friend referral page here, and your friend will get a $25 discount using a Bertesian referral coupon code if they buy a Bartesian after using your link. You’ll also get 2,500 points on the Bartesian Rewards Club. Which is to say, you also get $25.

#Top #Bartesian #Discount #Codescoupons,shopping">Top Bartesian Discount Codes: 35% Off

Bartesian is the Keurig of cocktails. After trying several automatic cocktail makers on the market, it was the only cocktail maker I could see fitting into my normal routine. It works like any capsule-style device, but with booze. You fill the Bartesian’s glass bottles with your liquor of choice, make sure there’s water in the reservoir, plop in a cocktail capsule (these typically cost $2-3), choose your drink strength, press “mix,” and then a drink comes out. (If you’ve got kids, the Bartesian Professional version comes with a lock that will stymie curious fingers.)

Do you need a Bartesian to make cocktails? Of course you don’t. You can dump tequila into sour mix anytime and call it a margarita. But perhaps you’d like to make an espresso martini, a blackberry margarita, and also a Long Island Iced Tea? The Bartesian is a sort of shortcut to a home bar, without having to store all the mixers—and a bit of a novelty. It will be fun, and silly, and the drinks are kind of fine in a Spring Break way: strong and sweet and with sometimes fun flavors. Don’t expect sophistication. Expect a bit of a party trick, the sort of thing that makes a summer a little more fun.

You’ll, of course, want a Bartesian coupon to make that fun more accessible. Luckily, the current Bartesian discount codes are good for up to 35% off.

Save up to 35% With a Bartesian Cocktail Subscription

Standard pods on the Bartesian come in packs of 8, for $20 to $25. But if you know you plan to use the cocktail machine often—garden parties, art gallery openings, a really cool barber shop, an interesting home life, Friday afternoon margaritaville—the easiest way to save on the Bartesian pods is to sign up for a cocktail subscription. No Bartesian subscription discount codes are required. Subscription boxes always cost $20, so get the ones that’d be otherwise expensive for a 20% discount—then get additional tiered discounts of Bartesian depending on volume and frequency. If you order often or in large quatnities, this can add up to 35% off the regular price.

Save 15% (Or More) When You Purchase a Cocktail Bundle

I can’t tell you what to do. But at current discounts on Bartesian cocktail bundles and add-ons, only a sucker buys a Bartesian as a standalone item. If you flip to the Bartesian bundles page, you can find multiple bundles that offer glassware and cocktail variety packs for about the same price as the machine by itself. The Mom Bundle in particular costs less than the Bartesian Pro machine by itself, but includes 8 margarita capsules and two glasses. As of April 2026, Bartesian is also offering a Mother’s Day deal, offering $100 off the Bartesian Pro or the Bartesian Duet as long as you add a cocktail capsule pack to your order. Presumably, if you are buying the machine, you’ll want the cocktail capsules anyway.

Bartesian Rewards Club: Get More for Your Buck

Bartesian also has a loyalty program that they’re calling, alternately, the Bartesian Club, the Bartesian Rewards Club, or Bartesian Mixologist Rewards. One way or the other, it doesn’t cost anything to sign up, and you get discounts. Basically, you earn 4 to 6 points per dollar you spend, plus get additional points for referring other customers, following Bartesian on Instagram, or just having a birthday. If you get a thousand points, you can redeem them for a $10 discount. There are also exclusive members-only tiers. Rewards are bigger if you’re a big spender. Here are the three membership tiers.

Earn 2,500 Points and Give $25 When You Refer a Friend

The biggest rewards bonus comes when you refer a friend who then buys a Bartesian or otherwise spends at least $150 on the site. Use the friend referral page here, and your friend will get a $25 discount using a Bertesian referral coupon code if they buy a Bartesian after using your link. You’ll also get 2,500 points on the Bartesian Rewards Club. Which is to say, you also get $25.

#Top #Bartesian #Discount #Codescoupons,shopping

Post Comment